The company was founded in 2006 by world-leading biochemist Professor Angus Lamond and post-doctoral researcher Dr. Paul Ajuh. Originally, the company operated as Dundee Cell Products Ltd and offered a diverse portfolio of products and services to the scientific community.
New technological developments and market changes lead to a company re-brand and change of focus. The newly named DC Biosciences would now use mass spectrometry to carry out the identification and quantification of proteomes or targeted proteins. The proteomic services ran alongside antibody production and click chemistry reagent sales.
Keiryn Bennett Ph.D. was welcomed to the DC Biosciences team as Lead Proteomic Scientist, bringing many years of highly focused knowledge in the field of proteomics. Dr. Bennett’s expertise, research experience, and enthusiasm make her ideally placed to advise customers on the best path to reach their specific goals.
The focus at DC Biosciences shifted once more to align with market requirements and to exploit resources. The main focus would now be on providing pioneering proteomic services in the areas of Protein Identification, Quantitative Proteomics, Affinity Proteomics, Post-Translational Modifications.